Couldn't have written this at a better time considering the rubbish that has been trampled out over the past week
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market